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T-cell-mediated immune responses play a fundamental role in controlling Mycobacterium 
tuberculosis (M. tuberculosis) infection, and traditionally, this response is thought to be 
mediated by Th1-type CD4+ T-cells secreting IFN-γ. While studying the function and 
specificity of M. tuberculosis-reactive CD4+ T-cells in more detail at the single cell 
level; however, we found a human CD4+ T-cell population with a naive phenotype that 
interestingly was capable of producing multiple cytokines (TCNP cells). CD4+ TCNP cells 
phenotyped as CD95lo CD28int CD49dhi CXCR3hi and showed a broad distribution of 
T cell receptor Vβ segments. They rapidly secreted multiple cytokines in response to 
different M. tuberculosis antigens, their frequency was increased during active disease, 
but was comparable to latent tuberculosis infection in treated TB patients. These results 
identify a novel human CD4+ T-cell subset involved in the human immune response to 
mycobacteria, which is present in active TB patients’ blood. These results significantly 
expand our understanding of the immune response in infectious diseases.
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inTrODUcTiOn
Several studies in experimental mouse models and in HIV-infected patients have underscored 
the essential role of CD4+ T-cells and Th1 immunity in protection against tuberculosis (TB) (1). 
Moreover, CD4+ T-cells producing one, two, or three cytokines (polyfunctional T cells) have been 
linked to bacterial load and disease activity in humans, as well as to protective TB to vaccine-induced 
responses in animal models of TB (2–4). Protective immune responses against mycobacterial infec-
tion are thought to be dependent on quality, as measured by the capacity of T cells to exert multiple 
Abbreviations: M. tuberculosis, mycobacterium tuberculosis; TB, tuberculosis; TCNP cells, cytokine-producing T cells with a 
naïve phenotype.
Table 1 | Characteristics of enrolled patients.
active Tb lTbi Past Tb Total
N (%) 18 (51.4) 7 (20.0) 10 (28.6) 35 (100.0)
Age median  
(IQR)
39 (29.0–43.5) 37 (28.0–63.0) 44.5 (34.0–51.0) 41 (29.0–45.0)
sex
Female N (%) 5 (27.8) 3 (42.9) 6 (60.0) 14 (40.0)
Origin
West Europe (%) 2 (11.1) 4 (57.1) 2 (20.0) 8 (22.9)
East Europe (%) 10 (55.6) 1 (14.3) 5 (50.0) 16 (45.7)
Asia (%) 2 (11.1) – – 2 (5.7)
Africa (%) 3 (16.7) 1 (14.3) 1 (10.0) 5 (14.3)
South America 1 (5.6) 1 (14.3) 2 (20.0) 4 (11.4)
bcg
Vaccinated (%) 16 (88.9) 3 (42.9) 8 (80.9) 27 (77.1)
QFT-iT
Positive (%) 12 (66.7) 7 (100.0) – 19 (54.3)
Negative (%) 2 (11.1) – – 2 (5.7)
Not done (%) 4 (22.2) – 10 (100.0) 14 (40.0)
Microbiological  
TB (%)
18 (100) – – 18 (100)
TB, tuberculosis; LTBI, latent tuberculosis infection; BCG, bacillus Calmette-Guérin; 
IQR, interquartile range; GTF, QuantiFERON-TB GOLD In-tube.
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functions, rather than on their magnitude, which is predomi-
nantly related to the frequency of antigen-specific T cells with a 
particular effector function (5, 6).
Detection of antigen-specific cytokine production in indivi-
dual T cells by intracellular cytokine staining and flow cytometry 
has been widely used to identify specific subsets of T cells produc-
ing different types of cytokines and to correlate their cytokine 
production patterns with functional phenotypes according to the 
expression of surface markers.
CD4+ T-cells can be divided into at least three different 
populations: naive (TN) referred to as CD45RA+CCR7+, central 
memory (TCM) as CD4R−CCR7+ and effector memory (TEM) as 
CD45RA−CCR7−. TEM cells rapidly respond to re-encounter of 
antigen, such as in re-infection, whereas TCM cells are long-lived 
T cells with self-renewal and a homeostatic proliferative capac-
ity that might contribute to their maintenance (7). In several 
infection models, including TB, TEM cells are expanded during 
active bacillary replication, while TCM cells are mostly detectable 
after control and eradication of infection (4, 8), indicating that 
distinct memory phenotypes and functions are associated with 
different stages of infection.
In the present study, we performed a broad phenotypic and 
functional characterization of M. tuberculosis-specific CD4+ 
T-cells to evaluate whether distinct T cell functional signatures 
could be correlated with cell surface memory and effector pheno-
types in the different phases of infection and disease.
We used additional surface markers, such as CD28 and CD95, 
which allow the identification of six CD4+ T cell subsets in the 
peripheral blood of healthy human beings (9). Moreover, we 
analyzed the expression of other molecules mediating lympho-
cyte functions, including the CD49d integrin and the CXCR3 
chemokine receptor, which is expressed on IFN-γ-producing 
Th1  cells and allows cells to traffic rapidly to inflamed tissues. 
Unexpectedly, this approach revealed the existence of a novel 
human CD4+ T  cell subset in TB, which is antigen specific, 
associated with disease activity, and expresses an undescribed 
phenotype, which explains why these cells have not been detected.
MaTerials anD MeThODs
human subjects
Peripheral blood was obtained from 18 adults with pulmonary 
TB disease (Table  1) recruited from the National Institute for 
Infectious diseases L. Spallanzani (INMI) in Rome. The majority 
of TB patients had been vaccinated with bacillus Calmette-
Guérin, none had evidence of HIV infection, or was being 
treated with steroid or other immunosuppressive. Active TB 
microbiologically diagnosed was defined based on the M. tuber-
culosis isolation from sputum culture. All patients were treated 
in accordance with Italian guidelines and received therapy for 
6  months. Treatment was successful in all participants, as evi-
denced by the absence of any clinical or radiographic evidence of 
recurrent disease and sterile mycobacterial cultures at the end of 
treatment. Peripheral blood from patients was collected within 
8  days of specific treatment initiation and, in some patients, 
after completion of chemotherapy (TB-6). Latent tuberculosis 
infection (LTBI) individuals reported household or equivalent 
close contact (work) with smear-positive pulmonary TB patients 
in the previous 3 months, and scored positive in QuantiFERON 
Gold In-Tube (QFT IT, Qiagen) with no active TB lesions at 
chest radiography and had not received any prior preventive 
therapy (10, 11). Table 1 reports the characteristics of the enrolled 
subjects included in this study. The study was approved by the 
Ethical Committee of the University Hospital in Palermo (approval 
number 13/2013) and of INMI, approval number 72/2015. 
Informed written consent was provided by all participants.
short-Term In Vitro stimulation and 
intracellular Facs analysis
Peripheral blood was collected in heparin tubes, and peripheral 
blood mononuclear cells (PBMC) were isolated by Ficoll–
Hypaque density gradient centrifugation (Euroclone). Recovered 
PBMCs were counted using a hemocytometer and viability, 
as tested by trypan blue exclusion, was always >95%. Peptide 
pools covering the whole sequences of ESAT-6 and CFP-10 
M. tuberculosis proteins were used, as well as recombinant 
Ag85B and Acr proteins expressed in Escherichia coli and puri-
fied as previously described (12). PBMCs (106/mL) were stimu-
lated with M. tuberculosis antigens at a final concentration of 
10 µg/mL or Ionomycin (Sigma, St. Louis, MO, USA, 1 µg/mL 
final concentration) and phorbolmyristate acetate (PMA, Sigma, 
150 ng/mL final concentration). Cells were cultured in a humi-
dified incubator at 37°C with 5% CO2 for 6 h in the presence of 
5  µg/mL Brefeldin A (Sigma, St. Louis, MO, USA). Following 
incubation, PBMCs were harvested, washed in PBS containing 
1% FCS and 0.1% sodium azide, and then stained with the anti-
bodies (Table S1 in Supplementary Material) in incubation buffer 
(PBS-1% FCS-0.1% Na azide) for 30 min at 4°C, as indicated by 
Cossarizza et al. (13).
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Subsequently, PBMCs were washed, fixed, and permeabilized 
(Cytofix/Cytoperm Kit, BD Pharmingen) according to the manu-
facturer’s instructions and stained for intracellular cytokines with 
conjugated anti-IFN-γ, anti-IL-2 and TNF-α mAbs (see Table 
S1 in Supplementary Material). Isotype-matched control mAbs 
were used. All mAbs were from BD Pharmingen (San Josè, CA, 
USA). Cells were washed, fixed in 1% paraformaldehyde, and at 
least 1 ×  106 lymphocytes were acquired using a FACSARIA I 
(BD Biosciences), following gating according to forward and side 
scatter plots. FACS plots were analyzed using FlowJo software 
(version 6.1.1; Tree Star, Ashland, OR, USA).
The median background staining level observed in the medium 
control was 0.02% based on viable CD4+ lymphocytes for IFN-γ. 
A detected antigen-specific response was defined as a response 
where the percentage of cytokine-positive CD4+ lymphocytes 
was at least twofold above the background observed in the 
medium control and at the difference between specific response 
and background level being >0.01%.
The experiments of in vitro stimulation were performed on a 
median PBMC cell count of 1.5 × 106 cells with a minimum of 
9 × 105 viable cells upon Ficoll–Hypaque recovery and a maxi-
mum of 1.7 × 106 cells being acquired. A minimum of 5 × 105 
CD4+ T cells were acquired on the viable lymphocyte gate and 
population of IFN-γ+CD4+ T cells more than 50 cells were con-
sidered for further analysis.
Facs analysis of the Tcr-Vβ repertoire
The IOTest Beta Mark TCR-Vβ Repertoire kit (Beckman Coulter, 
Miami, FL, USA) was used for the assessment of the following 
TCR-Vβ regions: Vβ1, Vβ2, Vβ3, Vβ4, Vβ5.1, Vβ5.2, Vβ5.3, 
Vβ7.1, Vβ7.2, Vβ8, Vβ9, Vβ11, Vβ12, Vβ13.1, Vβ13.2, Vβ13.6, 
Vβ14, Vβ16, Vβ17, Vβ18, Vβ20, Vβ21.3, Vβ22, and Vβ23. This 
kit includes 8 cocktails, each containing antibodies against 3 dif-
ferent TCR-Vβ regions covering a total of 24 TCR-Vβ regions 
and approximately 70% of the normal human TCR-Vβ repertoire. 
In performing the TCR-Vβ repertoire assay, anti-IFN-γ APC, 
anti-CD3 BV510, anti-CD4 PercPCy5.5, anti-CD45RA BV450, 
and anti-CCR7 PECy7 were added to the 8 Vβ cocktails. TCR-
Vβ antigen usage was analyzed by using general gating strategies 
based on amine-reactive LIVE/DEAD fixable NIR dead cells 
exclusion. Selected T-cell populations per each gating strategy 
were analyzed for TCR-Vβ expression and quantitation. The 
values were compared to published normal ranges provided by 
the manufacturer.
spanning-Tree Progression analysis  
of Density-normalized events (sPaDe) 
analysis
FACS plots (FCS files) were first analyzed by FlowJo and upon 
gating performed as above described, a new FCS file was gener-
ated (exported.FCS3.fcs), which was imported into the SPADE 
software. SPADE clustering algorithm on the https://Cytobank.
org platform was performed in four steps as described by Qiu 
et al. (14): (a) density-dependent downsampling to equalize the 
density in the point cloud of cells, (b) agglomerative clustering to 
partition the point cloud of cells into cell clusters, (c) minimum 
spanning tree construction to link the cell clusters, and (d) up 
sampling to map all the cells onto the resulting tree structure. 
A detailed description of each step is found in Ref. (14). SPADE 
analysis was performed to visualize single cells, among live 
CD3+CD4+ lymphocytes from all patients with active TB. The 
nodes of the tree reproduce clusters of cells that are similar in 
terms of marker expression, the color indicates intensity of the 
different marker staining, presented as arbitrary relative median 
fluorescence intensity and indicated with a heat map. This tree is 
constituted by an interconnected cluster of nodes, or clusters of 
connected nodes, which correspond with phenotypically defined 
CD4 T cell populations. SPADE uses the size and color of each 
node to signify the number of cells and median marker expres-
sion, respectively.
statistical analysis
Statistical significance (p values) of the magnitude of responses 
was calculated with unpaired two-tailed Student’s t-test. 
Kruskal–Wallis and Mann–Whitney test were used as non 
parametric test. Data were analyzed using statistical software 
SYSTAT 11 (Systat Software) or Graph Pad Prism (4.02) (Graph 
Pad Software).
resUlTs
iFn-γ Production by M. tuberculosis-
specific cD4 T-cells With a naive 
Phenotype
Peripheral blood mononuclear cells from patients with active 
TB disease, were stimulated for 6 h with a pool of peptides span-
ning the whole sequences of M. tuberculosis ESAT-6 and CFP-10 
antigens and assessed for intracellular interferon-γ (IFN-γ). 
We then performed flow cytometric analyses to determine 
memory subset phenotypes of antigen-specific CD4+ T-cells, based 
on their expression of CCR7 and CD45RA (7) (Figures 1A,B). 
As expected, the majority (~60%) of IFN-γ+ CD4+ T-cells 
responding to ESAT-6/CFP-10 in patients with active TB 
disease lacked surface expression of CD45RA and CCR7, 
compatible with a TEM phenotype, while 10–28% of IFN-γ+  
CD4+ T-cells expressed CCR7 but not CD45RA, consistent 
with a TCM phenotype. However, and surprisingly, a sizeable 
yet variable fraction (5–24%) of CD4+ T-cells responding to 
ESAT6/CFP-10 in patients with active TB disease had a naive 
(TN, CD45RA+CCR7+) membrane expression phenotype. 
Figure 1A shows the gating strategy used to select CD4+ T cells 
and comprise of sequential gating, dump channel (excluding 
dead cells, CD19 and CD14 cells) vs CD3+, single live cells, and 
CD4+vs IFN-γ+cells, and Figure 1B shows cumulative data of 
the phenotype distribution of IFN-γ-producing CD4+ T  cells 
from 18 patients with active TB disease. To better define this 
population of CD4+ T-cells with an apparent naive phenotype 
that nevertheless produced IFN-γ in response to M. tuberculosis 
antigens, expression of CD95, CD49d, CXCR3, and CD28 by 
different subsets of IFN-γ+ CD4+ T cells was compared to bulk 
(IFN-γ− cells) TN, TCM, and TEM cells (Figure  2). Virtually, 
all M. tuberculosis-specific IFN-γ+ CD4+ T-cells expressed 
FigUre 1 | Expansion of CD4+ T-cells with a naive phenotype (CD4+ TCNP cells) in patients with active TB. (a) Flow cytometry analysis of peripheral blood 
mononuclear cells (PBMC) from one representative TB patient. PBMCs were stimulated with ESAT-6/CFP-10 peptides for 6 h as described under Section  
“Materials and Methods.” Cells were acquired by a FACSAria I and were gated according to the illustration, as follows: initial gate on dump channel (excluding  
dead cells, CD19, and CD14 cells) vs CD3+, single live cells, and CD4+ vs IFN-γ cells. M. tuberculosis-specific (CD4+IFN-γ+) and bulk (CD4+IFN-γ−) cells were  
further distinguished in TCNP, TN, TCM, and TEM based on differential expression of CD45RA and CCR7, CD28, CD49d, CD95 and CXCR3 expression was finally 
evaluated on these differentially-gated populations. (b) Cumulative data on the frequencies of ESAT-6/CFP-10-specific CD4+IFN-γ+ TCNP (CD45RA+CCR7+CD28+, 
CD49d+CXCR3+CD95−), TCM (CD45RA−CCR7+) and TEM (CD45RA−CCR7−) cells in peripheral blood of 18 patients with active TB. Horizontal lines indicate the mean.
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CD28, CD49d, with relatively large proportions also express-
ing CXCR3, only a very small proportion of CD4+TCNP cells 
expressed CD95. Therefore, and with the exception of CD95, the 
phenotypic profile of IFN-γ+CD4+ TN-cells was comparable to 
that of IFN-γ+CD4+ TCM and TEM cells. Compared to bulk CD4+ 
TN cells, IFNγ+CD4+ T-cells with the naive surface phenotype 
could be distinguished by differential expression of CXCR3, 
with the latter containing a significantly larger proportion of 
cells expressing CXCR3 (median = 65%), while this was barely 
detectable in the former (median = 5%).
Thus, this analysis identifies a phenotypically naïve, ESAT-6/
CFP-10-specific, IFN-γ+CD4+ CD45RA+CCR7+ population that 
expresses cell surface CD95+CD28+CD49d+CXCR3+. These 
CD4+ T-cells with a naive phenotype but producing cytokines 
were designated TCNP cells (cells with naive phenotype that are 
able to produce cytokines).
In 5/18 patients with active TB disease, we detected two dif-
ferent populations of IFN-γ-producing CD4+ T cells, one IFN-
γhigh and one IFN-γlow: as shown in Figure S1 in Supplementary 
Material, the IFN-γlow CD4 T-cells coincided with the TCNP popu-
lation, while the IFN-γhigh CD4+ T cell population predominantly 
expressed a TEM phenotype.
To better define the IFN-γ profiles of CD4 TCNP cells, we used 
the SPADE algorithm, which distinguishes cell subsets by clus-
tering, based on surface antigen expression identified by a color 
gradient.
FigUre 2 | Phenotype distribution and frequencies of CD4+IFN-γ+ and CD4+IFN-γ− T-cell subsets. Violin plot depicting the proportion of cell surface markers 
expressed by bulk TN, TCM, and TEM CD4+ T cells, and Mycobacterium tuberculosis-specific CD4+IFN-γ+ TCNP, TCM, and TEM (n = 18 active TB patients). Violin plot 
summarizes the full distribution of the data by density estimation and probability by interquartile range and median (black line). The extremities represent the 95% 
confidence interval with higher and lower probability respectively. ***p = p < 0.001, a value was calculated by Mann–Whitney test.
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As shown in Figure 3, the expression of five T-cell-activation 
and -differentiation markers (CD45RA, CCR7, CD95, CD49d, 
CXCR3) distinguished discrete IFN-γ-producing T-cell sub-
sets among PBMCs stimulated with ESAT-6/CFP10 antigens. 
As expected, the highest IFN-γ staining intensity was detected 
amongst cell populations, which stained negative for both 
CD45RA and CCR7 and thus likely corresponding to canoni-
cal TEM cells. The TN cell subset, as identified by the expression 
of CD45RA+CCR7+, was further split into several nodes, 16 of 
which corresponded to canonical TN cells and 17 nodes enriched 
for IFN-γ-producing cells, thus identifying the TCNP subset 
(Figure 3). The analysis of the mean fluorescence intensity fur-
ther revealed that CD4+IFN-γ +TCNP cells had higher expression 
of CCR7, CD45RA, and CXCR3, intermediate expression of 
CD49d and very low, if any CD95 expression. Hence, SPADE 
analysis confirmed that the phenotypic profile of ESAT-6/CFP10-
specific CD4+IFN-γ+ TCNP cells was markedly distinct from that 
of TN, TSCM, TCM, or TEM cells (9).
We next assessed the TCR diversity of the CD4+ TCNP cells 
by flow cytometry using antibodies specific for the 24 different 
TCR β-chain variable (Vβ) regions, which cover 70% of the 
total Vβ repertoire in three patients. Figure 4 shows that TCNP 
cells had an overall broad distribution of different Vβ gene 
segments, but some Vβ families (Vβ5.1, Vβ7.1, Vβ8, Vβ12, 
Vβ13.2, Vβ16, and Vβ17) were similarly expressed in CD4+ 
TCNP and in the most differentiated CD4+ TEM cells, suggest-
ing that the CD4 TCNP cell population might have arisen in 
response to M. tuberculosis antigens that drove the generation 
of CD4 TEM cells, in a putative linear differentiation model (7). 
Of note, M. tuberculosis-specific IFN-γ+CD4+ TEM cells had 
a dominant Vβ22 gene expression and, Vβ13.1, most likely 
reflecting the emergence of antigen-specific IFN-γ+CD4+ 
T effector cells as dominant clones during M. tuberculosis 
infection.
cD4+ TcnP cells recognize Multiple  
M. tuberculosis antigens and are 
Polyfunctional
In addition to ESAT-6/CFP-10, antigen (Ag)85B and α-crystallin 
(Acr, HspX, Rv2031c), which are expressed at different stages of 
M. tuberculosis infection (15) were used to stimulate PBMCs 
from 18 patients with active TB. As shown in Figure 5, 4–15% of 
IFN-γ producing CD4+ T cells specific for Ag85B in TB patients 
exhibited the TCNP phenotype, and a similar fraction (12–25%) 
of IFN-γ-producing CD4+ TCNP cells was found in response to 
Acr. These results indicate that CD4+ TCNP cells are a common 
feature of the global immune response to M. tuberculosis. In both 
instances, the proportion of unstimulated CD4+ T  cells with a 
TN phenotype that produced IFN-γ (TCNP cells) was <0.01%. 
FigUre 4 | TCNP cells have a broad TCR Vβ repertoire. Distribution of TCR Vβ in each of the 24 TCR Vβ regions assessed (horizontal axis) in the CD4TN, CD4TCNP, 
CD4TEM, and bulk CD4+ T-cells, analyzed on the basis of IFN-γ production and on the expression of CCR7 and CD45RA of three representative patients with active 
TB. Clonogram represents the mean of the 24 TCR Vβ expression of the three patients. *p < 0.05 when TEM subset was compared to TCNP subset and ***p < 0.001 
when TEM subset was compared to the all subsets.
FigUre 3 | SPADE analysis of CD4+TCNP cells. CD3+CD4+ single cells were used to generate the SPADE tree. CD4 T-cells were analyzed for IFN-γexpression and 
according to the expression of CCR7 and CD45RA expression. The color patterns indicate that the nodes contained cells that express the same surface marker. 
The distribution of the major populations is shown for one representative sample. The branching tree is based on the number of cells included in each node and the 
legend indicates the range of cell per node according to relative median fluorescence intensity of 1 out of 18 TB patients in response to ESAT6/CFP10 after 6 h of 
in vitro stimulation.
6
Orlando et al. M. tuberculosis-Specific CD4 TCNP Cells
Frontiers in Immunology | www.frontiersin.org May 2018 | Volume 9 | Article 1119
Similarly, we consistently failed to detect CD4+ TN cells making 
IFN-γ among PBMC of healthy age- and sex-matched healthy 
PPD− control individuals (data not shown). However, following 
6 h stimulation of PBMCs from healthy donors with ionomycin 
and PMA, 0.5–4% of CD4+ TN cells expressed IFN-γ (data not 
shown).
FigUre 5 | Broad antigen repertoire and polyfunctionality of CD4+TCNP cells. 
(a) Cumulative data on the frequencies of ESAT-6/CFP10, Ag85B- and 
Acr-specific CD4+IFN-γ+TCNP cells in peripheral blood of 15 patients with 
active TB disease. Horizontal lines indicate the mean. (b) peripheral blood 
mononuclear cells were stimulated with ESAT-6/CFP10 peptides, Ag85B, 
and Acr protein antigens and CD4+ T-cell subsets simultaneously expressing 
IFN-γ, TNF-α, and IL-2 were gated. Triple cytokine-positive CD4+ T cells were 
then gated on the basis of surface marker expression for CD45RA and CCR7 
to identify relative proportions of TCM, TCNP, and TEM subsets.
FigUre 6 | CD4+ TCNP cells correlate with active TB disease. Summary cumulative data of the frequency of CD4+ IFN-γ+ TCNP cells (a), TCM (b), and TEM (c) cells in 
patients with active TB, longitudinally assessed before the initiation of therapy (TB-0), compared to the same patients at the end of therapy, TB-6, and latent 
tuberculosis infection subjects. The boxes represent interquartile ranges; the line in the middle of the box represents the median, and minimum/maximum values are 
shown. Data are representative of three independent experiments. p-values were calculated by Kruskal–Wallis test. *p < 0.05 and ***p < 0.001 were considered 
statistically significant.
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As shown in Figure  6A, the proportion of CD4+ TCNP cells 
producing IFN-γ significantly decreased in cured TB patients. 
Similar results were obtained upon stimulation with Ag85B and 
Acr antigens (data not shown). Moreover, we determined whether 
the CD4+ TCNP population was detectable in subjects with latent 
M. tuberculosis infection (LTBI subjects). As shown in Figure 6A, 
active TB patients had significantly more TCNP cells when com-
pared to LTBI individuals.
For comparison, frequencies of M. tuberculosis-specific CD4+ 
TCM (Figure 6B) and TEM cells (Figure 6C) were very similar in the 
three tested groups, without significant difference among them.
To support the above data, we evaluated frequencies of IFN-γ-
producing naïve (CD45RA+CCR7+CD28+CD95−) CD4+ T cells 
in a different cohort of 10 patients with active TB before the 
initiation of therapy (TB-0), compared with blood samples from 
the same patients taken 6 months later, i.e., at the end of therapy 
(TB-6). As shown in Figure S2 in Supplementary Material, the 
frequency of the presumptive TN producing IFN-γ population 
declined in all tested patients after therapy, strongly supporting 
previous data obtained in patients with cured TB disease.
All together, these results indicate that M. tuberculosis-specific 
CD4+ TCNP cells are a novel T cell subset that is associated with 
active TB disease.
DiscUssiOn
CD4+ T-cell-mediated protection against a wide range of patho-
genic microorganisms is dependent on different types of Th cells 
endowed with distinct effector functions (16).
Our results identify a novel human memory CD4 T cell sub-
set with an unorthodox, TN-like phenotype, which is involved 
in the human immune response to mycobacteria, and which 
correlates with the presence of active TB disease during infec-
tion by M. tuberculosis. Following curative TB treatment, the 
size of this T cell subset significantly decreased, suggesting that 
these cells are markers of disease activity. Accordingly, LTBI 
subjects had a lower proportion of this CD4 T cell population 
in the peripheral blood.
This novel human T  cell subset was discovered during our 
studies to quantitate the proportion of functional CD4+ T cells, 
The polyfunctionality of CD4+ TCNP cells, defined as the 
simultaneous production of IFN-γ, IL-2, and TNF-α in response 
to stimulation with ESAT6/CFP-10 peptides or Ag85B or Acr 
proteins, was evaluated further. To this aim, we first gated on 
CD4+ cells expressing IFN-γ, IL-2, and TNF-α and then evalu-
ated their surface memory phenotypes. As shown in Figure 5B, 
an average 60% of the polyfunctional, triple cytokine positive 
(IFN-γ, IL-2, and TNF-α) CD4+ T cells had a TCNP phenotype, 
as compared to 15% with a TCM phenotype and 25% with a TEM 
phenotype. This indicates that the ESAT-6/CFP10-specific CD4+ 
TCNP cells are differentiated polyfunctional T-cells that differ 
both phenotypically and functionally from the quiescent CD4+ 
TN population.
cD4+ TcnP cell Frequencies in the blood 
correlate With active Tb Disease
We next determined whether the CD4+ TCNP population was 
stable over time by measuring their frequencies cross-sectionally 
in samples from 10 patients after completion of anti-TB therapy.
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using standard 6  h in  vitro stimulation with three different 
mycobacterial antigens (CFP10/Esat-6, Ag85, and Acr proteins) 
followed by intracellular FACS analysis to determine memory 
subset phenotypes of antigen-specific CD4+ T-cells, based on 
their expression of CCR7 and CD45RA (7). As expected, the 
majority of IFN-γ+CD4+ T cells responding to ESAT-6/CFP-10 
in patients with active TB disease had a TEM phenotype, while 
10–28% of IFN-γ+CD4+ T  cells displayed a TCM phenotype. 
Unexpectedly, we detected a sizeable cell population that 
phenotypically expressed a naive like phenotype yet produced 
antigen-induced IFN-γ+. We termed this population CD4+ TCNP 
due to their capacity to rapidly secrete multiple cytokines while 
expressing a naive phenotype.
IFN-γ profiles of CD4 TCNP cells were defined in more 
detail using additional cell surface markers and the SPADE 
algorithm-tool, which distinguishes cell subsets by clustering 
on the base of surface antigen expression identified by a color 
gradient. These analyses revealed that IFN-γ+CD4+ TCNP cells 
were further marked by expression of CCR7, CD45RA, CD28, 
CD49d and CXCR3, and very low, if any CD95 expression. 
This indicates that the phenotypic profile of ESAT-6/CFP10-
specific CD4+IFN-γ+ TCNP cells is distinct from that of TN, TSCM, 
TCM, or TEM cells. Moreover, analysis of TCR-Vβ gene usage 
showed that TCNP cells were not oligoclonal, but displayed 
highly heterogeneous Vβ gene segment usage. Vβ5.1, Vβ7.1, 
Vβ8, Vβ12, Vβ13.2, Vβ16, and Vβ17 families were similarly 
expressed among CD4+ TCNP and CD4+ TEM cells, suggesting 
that the CD4 TCNP cell population might have arisen in response 
to M. tuberculosis antigens that drove the generation of highly 
differentiated CD4 TEM cells (7). Of note, M. tuberculosis- 
specific IFN-γ+ CD4+ TEM cells showed expanded Vβ13.1 
and Vβ22 regions, likely reflecting the emergence of antigen-
specific IFN-γ+CD4+ T effector cells as dominant clones dur-
ing M. tuberculosis infection. Interestingly, previous studies in 
macaques have demonstrated that the Ag-specific CD4+IFN-
γ+against M. tuberculosis is characterized by the emergence of 
few dominant clones, which undergo major recall expansion 
and rapidly traffic to the lungs (17). However, additional data 
are needed due to the limited number of individuals that was 
tested for TCR Vβ repertoire.
CD4+ T  cells with a TCNP phenotype accounted for a large 
proportion, as an average 60% of triple cytokine-positive CD4+ 
T-cells had a TCNP phenotype cells, compared to only 15% express-
ing a TCM phenotype and 25% expressing a TEM phenotype. This 
indicates that the ESAT-6/CFP10-specific CD4+ TCNP cells are dif-
ferentiated polyfunctional T cells that differ both phenotypically 
and functionally from the quiescent CD4+ TN population.
Recent studies have shown that polyfunctional T  cells 
provide immune protection in viral infections such as HIV 
(18) while they are induced in response to a novel tuberculosis 
vaccine and their role is under investigation (19). They also cor-
related with protection in a murine Leishmania model (5) and 
in mouse models of TB vaccine-induced protection (20, 21). 
However, their role during human M. tuberculosis infection is 
controversial and less clear, and these cells do not seem to have 
the same protection-associated role as observed in chronic 
viral infections (22). Different authors have recently shown 
that polyfunctional T  cell responses result from a sequential 
release of cytokines, with very short periods of time in which 
cells secrete multiple cytokines simultaneously. These results, 
along with differences in methodological aspects such as cul-
ture time, the use of peptide pools or fusion proteins compared 
to recombinant proteins used, the criteria to select TB patients, 
might explain the discordant results, and should be taken into 
account.
Additional work will obviously be needed to address 
whether the developmental fate of CD4+TCNP cells intersects 
with that of any other subset, and in particular with CD4+ 
TSCM cells, despite the differential expression of certain 
surface markers, such as CD95 [as shown here and in Ref. 
(16)]. Our results reported here are in agreement with data 
on CD8+ T cells reported by Nikolich-Zugich and coworkers 
(23) showing that West Nile virus infection resulted in the 
expansion of CD8+ T cells producing IFN-γ while expressing 
a naive phenotype, which were termed TMNP cells. These TMNP 
cells were specifically present in symptomatic subjects, sug-
gesting that their frequency and numbers correlated with the 
severity of acute viral infection. Finally, also Scriba et al. (24) 
have identified M. tuberculosis-specific CD4+ T cells that were 
induced by primary M. tuberculosis infection and displayed a 
TSCM phenotype while also being capable of producing IL-2, 
TNF-α, and IFN-γ and, in agreement with the TCNP popula-
tion we have described here, which predominantly expresses 
CXCR3.
Whether or not the CD4+ TCNP cells here described represent 
a defined and stable T cell subset (25–27) or rather a transient 
population, and how it is related or not to TSCM cells remains to be 
determined. CD4+ TCNP cells express CXCR3 and CD49d, which 
allow them to rapidly traffic to sites of M. tuberculosis infection 
and engage in the control of bacterial replication by virtue of 
their ability to secrete the type-1 cytokines, IFN-γ, and TNF-α, 
which are well known players in antimycobacterial protective 
immune responses. Moreover, as their number also correlates 
with the presence of active TB disease, they might also serve as a 
TB specific biomarker of disease as well as a successful response 
to chemotherapy even if this finding requires to be validated 
in detail in follow up studies with dense sampling during TB 
treatment.
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FigUre s1 | CD4+ T-cells with a naive phenotype (CD4+TCNP cells) are found 
among IFN-γlow CD4+ T cells in patients with active TB. Flow cytometry analysis 
of peripheral blood mononuclear cells from one representative TB patient. Cells 
were stimulated with ESAT6/CFP10 peptides for 6 h as described in the Section 
“Materials and Methods” and analysis of cell surface marker expression was 
differentially performed on the gated CD4+IFN-γhigh and CD4+IFN-γlow populations, 
demonstrating that the former expresses a TEM phenotype and the latter a TCNP 
phenotype.
FigUre s2 | Interferon-γ (IFN-γ)-producing naïve CD4+ T cells are linked  
to active TB disease. Quantification of IFN-γ-producing naïve 
(CD45RA+CCR7+CD28+CD95−) CD4+ T cells in a different cohort of 10 patients 
with active TB disease, longitudinally assessed before the initiation of therapy 
(TB-0) compared with blood samples from the same patients taken 6 months 
later, i.e. at the end of therapy (TB-6).
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